Elizabeth E. Reed, Chief Legal Officer and GC at Travere Therapeutics, Inc. (TVTX), sold 24,250 shares at $45.00 ($1.1M) on 2026-05-04, disclosed to the SEC on 2026-05-06.
Scheduled sale ($1.1M) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 20,000 | $900K | 82.4% |
| 2 | $46.65 | 2,174 | $101K | 9.3% |
| 3 | $43.95 | 2,076 | $91K | 8.4% |
| Total | $45.06 avg | 24,250 | $1.1M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |
| TVTX | SELL | 2026-02-19 | $557K | — | Filing → |